Seeing Is Believing
Eliem Therapeutics's activity chart (see below) currently has 8 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 361.43 days.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 08-Mar-2023. First documented stock forecast 07-Sep-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Mar-2023
$6
$2.91 (94.17%)
3 years 7 months 24 days ago
(08-Mar-2023)
2/2 (100%)
$2.36 (64.84%)
485
Buy Since 07-Sep-2021
$4
$0.91 (29.45%)
4 years 2 months 16 days ago
(16-Aug-2022)
1/2 (50%)
$1.11 (38.41%)
141
Buy Since 07-Sep-2021
$8
$4.91 (158.90%)
4 years 2 months 30 days ago
(02-Aug-2022)
1/4 (25%)
$5.28 (194.12%)
639
Hold Since 26-Apr-2022
$32
4 years 6 months 6 days ago
(26-Apr-2022)
0/1 (0%)
$3.39 (11.85%)
What is ELYM (Eliem Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ELYM (Eliem Therapeutics)?
Which analyst has the most public recommendations on ELYM (Eliem Therapeutics)?
Which analyst is the currently most bullish on ELYM (Eliem Therapeutics)?
Which analyst is the currently most reserved on ELYM (Eliem Therapeutics)?